Thursday, Somanetics Corp. (SMTS) reported a decline in third-quarter net income to $2.23 million or $0.17 per share from $3.05 million or $0.23 per share in the prior year period. On average, 6 analysts polled by Thomson Reuters expected earnings per share of $0.14. Analysts' estimate typically excludes one-time items.
Net revenues for the third quarter increased to $12.51 million from $12.37 million in the year earlier period. Four analysts estimated revenues of $13.09 million for the quarter.
Somanetics signed a three-year extension of its exclusive distribution agreement with Covidien for Europe, the Middle East and Africa.
Somanetics reiterated its fiscal 2009 net revenues guidance, expecting it to lie between $50 million and $52 million. Fiscal 2009 income before income taxes are still expected to be in the range of $11.2 million to $11.6 million. Four analysts estimate revenues of $50.60 million for fiscal 2009.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.